| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 120.537 | 121.542 | 139.631 | 147.295 | 171.462 | 185.680 | 203.123 | 205.868 | 251.849 | 275.276 |
| Total Income - EUR | 120.543 | 121.542 | 139.632 | 147.629 | 171.463 | 185.714 | 203.185 | 206.953 | 251.893 | 275.283 |
| Total Expenses - EUR | 121.593 | 119.670 | 136.290 | 141.535 | 163.010 | 175.096 | 188.619 | 190.645 | 227.562 | 249.564 |
| Gross Profit/Loss - EUR | -1.049 | 1.872 | 3.342 | 6.095 | 8.453 | 10.618 | 14.567 | 16.308 | 24.331 | 25.719 |
| Net Profit/Loss - EUR | -1.209 | 690 | 1.943 | 4.618 | 7.256 | 8.984 | 12.575 | 14.280 | 21.197 | 21.686 |
| Employees | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Farmacia Larysan S.r.l.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 19.201 | 9.221 | 1.761 | 0 | 328 | 160 | 23 | 0 | 0 | 0 |
| Current Assets | 51.523 | 68.594 | 83.232 | 88.661 | 100.420 | 93.448 | 98.722 | 103.753 | 119.266 | 134.814 |
| Inventories | 30.917 | 40.837 | 40.237 | 50.198 | 51.942 | 45.061 | 44.482 | 49.611 | 53.673 | 63.777 |
| Receivables | 7.780 | 25.608 | 40.211 | 37.303 | 44.346 | 46.976 | 52.046 | 50.973 | 49.411 | 66.291 |
| Cash | 12.826 | 2.149 | 2.783 | 1.159 | 4.133 | 1.411 | 2.194 | 3.169 | 16.182 | 4.746 |
| Shareholders Funds | 5.158 | 5.783 | 7.621 | 12.092 | 13.731 | 20.582 | 12.648 | 14.353 | 35.469 | 21.758 |
| Social Capital | 45 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 | 60 |
| Debts | 65.566 | 72.032 | 77.372 | 76.569 | 87.017 | 73.026 | 86.097 | 89.400 | 83.797 | 113.056 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 5.0415 | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Larysan S.r.l.